My question is whether Neptune Technologies & Bioressources stock is something you could see as a small position for the aggressive portion of a portfolio. Thanks.

Neptune Technologies & Bioressources Inc., $2.06, symbol NTB on Toronto (Shares outstanding: 75.0 million; Market cap: $159.7 million; www.neptunebiotech.com), makes omega-3 dietary supplements using a patented process for extracting oil from krill. (Krill are shrimp-like deepwater invertebrates that range in length from half an inch… Read More

World’s biggest generic drug maker keeps growing

Pat McKeough responds to many personal questions about specific stocks and other investment topics from the members of his Inner Circle. Every week, his comments and recommendations on the most intriguing questions of the past week go out to all Inner Circle members. And each… Read More

Hi Pat: What are your thoughts on Teva Pharmaceuticals?

Teva Pharmaceutical Industries Ltd. ADRs, $43.71, symbol TEVA on Nasdaq (ADRs outstanding: 942.4 million; Market cap: $41.2 billion; www.tevapharm.com), is the world’s largest generic drug maker.

In 2011, Israel-based Teva got 56% of its sales by making and selling more than 500 generic drugs.

The company also… Read More

Pat: Can I have your view on Teva Pharmaceutical? Thank you.

Teva Pharmaceutical Industries Ltd. ADRs, $38.45, symbol TEVA on Nasdaq (ADRs outstanding: 941.0 million; Market cap: $36.2 billion; www.tevapharm.com), is the world’s largest generic drug maker.

Israel-based Teva makes and sells more than 500 generic drugs in North America, which accounts for 50% of its… Read More